ArticleCrystal growth & design2025
Crystal Morphology and Associated Face-Specific Growth Kinetics of Tolfenamic Acid as a Function of Its Solution Crystallization Environment.
Article in Crystal growth & design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Molecular, Crystal, and Surface Chemistry ofCrystal growth & design · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The crystal morphology and face-specific growth kinetics of tolfenamic acid (TFA) forms I and II are investigated through an integrated molecular modeling and experimental approach. Morphology predictions based on attachment energy calculations are consistent with experimental observations, with needle-like habits for both forms, although with some subtle differences in the capping faces formed, which can be attributed to the variations in intermolecular packing and surface chemistry. The solvent polarity is found to significantly influence the crystal growth of both forms: for instance, polar solvents, such as ethanol, promote higher aspect ratios by disrupting hydrogen bonding at prismatic faces, while nonpolar solvents, such as toluene, are found to hinder elongation of the crystal habit by providing strong solute/solvent aromatic stacking interactions at the capping faces. Examination of the measured growth rates for form I in ethanolic solutions reveals markedly slower growth rates (0-0.02 μm/s) on the prismatic faces (e.g., {0 1 1}) when compared to the capping faces e.g., {1 0 0} (0.044-0.555 μm/s), consistent with the lower surface intermolecular unsaturation and limited solute binding on the former faces. Examination shows that the facet crystal growth rates of form II (at a supersaturation of 0.3) are higher than that for form I for both capping and prismatic faces, consistent with the ease of crystallization of form II in ethanolic solutions. Analysis of the growth rate data for form I as a function of supersaturation reveals a good fit using a BCF model, with the surface integration at the crystal/solution interface rather than solute mass transfer in the bulk solution being identified as the rate-limiting step for the prismatic faces. This is in contrast to the capping faces, which is found to be less well-defined with mass transfer and surface integration being more balanced depending on the degree of solution supersaturation. The interplay between solvent-dependent surface interactions and intermolecular packing with the crystal face-specific growth kinetics is highlighted, contributing well toward the development of a predictive framework for the design and control of the solid-form properties of organic materials.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.